CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
Quick Stats
Jan 30, 202650.0
AI Score
HOLD0.24
Volume Ratio
Next Earnings
12
+ve Days (30d)
17
-ve Days (30d)
GDTC Stock Summary
Last updated Jan 30, 2026
GDTC is currently trading at $0.8066, positioned below its 200-day moving average of $1.94, suggesting bearish momentum. The stock has a 52-week range of $0.7282 to $3.68.
Technical Analysis: The 50-day moving average stands at $1.44, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 25.424, suggesting the stock is oversold and potentially undervalued.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.337, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates GDTC at 50.0/100 with a HOLD recommendation.
GDTC (CytoMed Therapeutics Limited Ordinary Shares) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 25.424 |
| CMF (20) | -0.337 |
| ROC (10) | -13.269 |
| ADX (14) | 26.109 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.187 |
| AROONOSC (14) | -64.286 |
| WILLAMS %R (14) | -88.154 |
| MFI (14) | 53.813 |
GDTC Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
GDTC Price vs Max Options Open Interest
GDTC Max Change In Options Open Interest
GDTC Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GDTC Daily Out of Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GDTC Daily In the Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GDTC Most Active Options by Volume(near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CytoMed Therapeutics Limited Ordinary Shares is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
GDTC Moving Averages Analysis
GDTC (CytoMed Therapeutics Limited Ordinary Shares) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 0.92 |
| 20 | 1.08 |
| 30 | 1.22 |
| 50 | 1.44 |
| 100 | 1.78 |
| 200 | 1.94 |
GDTC Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 22.5 million |
| Earnings/Share ($) | -0.25 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0 |
| EPS Estimate Next Year ($) | 0 |
| WallStreet Target Price ($) | 5 |
| Most Recent Quarter |